Cardiac Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecast to 2017 Global Cardiac Markers Market is Forecast to Exceed $1 billion by 2017 The global cardiac markers market is forecast to exceed $1 billion by 2017, growing at a Compound Annual Growth Rate (CAGR) of 6% during 2010-2017. The global cardiac markers market expects to grow due to increasing incidence of cardiovascular diseases. The market is also expected to be driven by increased emphasis on Point of care testing (POCT), new and innovative products in the pipeline and cost-cutting measures such as laboratory automation. Increasing awareness of early detection and screening of cardiovascular diseases is also contributing to the growth of cardiac markers market. The US is the biggest market for cardiac markers. The US market was valued at $209m in 2010 and expected to grow at a CAGR of 6% to reach $320.6m in 2017, contributing 30% towards the global cardiac markers market. The market is expected to receive a boost from the recent advancements in the field of cardiac marker analysers. However the market is focusing towards cost-effective diagnostic tests because of the market’s low reimbursement level and rising pressure on the healthcare infrastructure to reduce the prices of the testing. Thus, POCT is increasingly used in order to reduce the cost of diagnosis, time of intervention and the number of patients admitted to coronary care units. For Sample Pages, please click or add the below link to your browser: http://www.globaldata.com/reportstore/RequestSamplePages.aspx?ID=Cardiac-MarkersGlobal-Pipeline-Analysis-Competitive-Landscape-and-Market-Forecasts-to2017&Title=Medical_Devices&ReportType=Industry_Report LOC devices are cost-effective, convenient for physicians as they can perform procedures in-office and the majority of LOC devices provide accurate results for cardiac markers within a few minutes. These are the latest and most cost-effective trends in the cardiac markers market. There is one more trend which is affecting every healthcare market; personalized medicine. It involves the systematic use of genetic or other information about an individual patient to select or optimize that patient's preventative and therapeutic care. With the help of this technique physicians are predicting the best treatments for heart disease with the help of predictive markers. GlobalData’s new report, “Cardiac Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017” provides key data, information and analysis on the global cardiac markers market. The report provides market landscape, competitive landscape and market trends information on the cardiac markers market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. For further details, please click or add the below link to your browser: http://www.globaldata.com/reportstore/Report.aspx?ID=Cardiac-Markers-GlobalPipeline-Analysis-Competitive-Landscape-and-Market-Forecasts-to2017&ReportType=Industry_Report&coreindustry=Industry_Report&Title=Medical_De vices Visit our report store: http://www.globaldata.com For more details contact: pressreleases@globaldata.com North America: +1 646 395 5477 Europe: +44 207 753 4299 +44 1204 543 533 Asia Pacific: +91 40 6616 6782